Interestingly, a recent study reported an OXPHOS transcriptional program in alveolar soft part sarcoma (ASPS), a distinct cancer also driven by TFE3 fusions; this suggests that the TFE3 fusion may drive similar metabolic programs across cancer types91. The gene discussed is TFE3; the disease is alveolar soft part sarcoma.